A network of medical institutions recognized for their expertise in diagnosing and treating myelodysplastic syndromes (MDS), participating in clinical trials, and contributing to ongoing research.

Studies conducted to evaluate the safety and effectiveness of new interventions for MDS, including drugs and procedures, with a structured process for patient identification, screening, enrollment, treatment, and follow-up.